ASX Mkt. Sensitive<p>Noxopharm ( <a href="https://mastodon-grafa.social/tags/NOX" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NOX</span></a> ) has released " Green light for HERACLES clinical trial " on Thu 29 May at 08:37 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ASX</span></a> <br><a href="https://grafa.com/asset/noxopharm-ltd-8713-nox.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nox.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/noxopharm-ltd-</span><span class="invisible">8713-nox.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nox.asx</span></a></p>